Vincerx Pharma (VINC) started shutdown measures after terminating its nonbinding letter of intent for a potential merger with Global Digital Holdings, operating as QumulusAI.
The board "authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities," Vincerx said Tuesday in a statement.